000 | 02327nam a22004457a 4500 | ||
---|---|---|---|
008 | 190314s20192019 xxu||||| |||| 00| 0 eng d | ||
022 | _a0889-8529 | ||
024 | _a10.1016/j.ecl.2018.11.005 [doi] | ||
024 | _aS0889-8529(18)30592-9 [pii] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a30717901 | ||
245 | _aConventional Radioiodine Therapy for Differentiated Thyroid Cancer. [Review] | ||
251 | _aEndocrinology & Metabolism Clinics of North America. 48(1):181-197, 2019 03. | ||
252 | _aEndocrinol Metab Clin North Am. 48(1):181-197, 2019 03. | ||
253 | _aEndocrinology and metabolism clinics of North America | ||
260 | _c2019 | ||
260 | _fFY2019 | ||
265 | _sppublish | ||
266 | _d2019-03-14 | ||
501 | _aAvailable online from MWHC library: 1996 - present | ||
520 | _aCopyright (c) 2018 Elsevier Inc. All rights reserved. | ||
520 | _aThis article presents an overview of the use of radioactive iodine (131-I) in the treatment of patients with differentiated thyroid cancer. Topics reviewed include definitions; staging; the 2 principal methods for selection of 131-I dosage; the indications for ablation, adjuvant treatment, and treatment; the recommendations for the use of 131-I contained in the guidelines of the American Thyroid Association and the Society of Nuclear Medicine and Molecular Imaging; the dosage recommendations and selection of dosage approach for 131-I by these organizations; the use of recombinant human thyrotropin for radioiodine ablation, adjuvant therapy, or treatment; and the MedStar Washington Hospital Center approach. | ||
546 | _aEnglish | ||
650 | _a*Iodine Radioisotopes/tu [Therapeutic Use] | ||
650 | _a*Thyroid Neoplasms/rt [Radiotherapy] | ||
650 | _aHumans | ||
650 | _aIodine Radioisotopes/ad [Administration & Dosage] | ||
651 | _aMedStar Health Research Institute | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aMedicine/Endocrinology | ||
656 | _aMedicine/Nuclear Medicine | ||
657 | _aJournal Article | ||
657 | _aReview | ||
700 | _aVan Nostrand, Douglas | ||
700 | _aWartofsky, Leonard | ||
700 | _aYlli, Dorina | ||
790 | _aVan Nostrand D, Wartofsky L, Ylli D | ||
856 |
_uhttps://dx.doi.org/10.1016/j.ecl.2018.11.005 _zhttps://dx.doi.org/10.1016/j.ecl.2018.11.005 |
||
942 |
_cART _dArticle |
||
999 |
_c4151 _d4151 |